Assessing antidepressant activity in rodents: recent developments and future needs
- PMID: 12008002
- DOI: 10.1016/s0165-6147(02)02017-5
Assessing antidepressant activity in rodents: recent developments and future needs
Abstract
Animal models are indispensable tools in the search to identify new antidepressant drugs and to provide insights into the neuropathology that underlies the idiopathic disease state of depression. As new targets are developed, both serendipitously and through hypothesis-driven research, existing animal paradigms are being modified and new tests are being developed to detect antidepressant actions of compounds acting on a broad range of neural and genetic targets. This review focuses on recent findings regarding some of the most widely employed animal models used currently to predict antidepressant potential. Emphasis is placed on recent modifications to such paradigms that have increased their utility and reliability. Furthermore, some key issues that need to be addressed for future discovery of novel antidepressant agents are examined, and the available data on genetically altered mice that might lead to the discovery of novel targets for antidepressant action are collated.
Similar articles
-
Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist.Pharmacol Biochem Behav. 2005 Aug;81(4):901-6. doi: 10.1016/j.pbb.2005.06.015. Pharmacol Biochem Behav. 2005. PMID: 16040106
-
Opioid system contribution to the antidepressant-like action of m-trifluoromethyl-diphenyl diselenide in mice: A compound devoid of tolerance and withdrawal syndrome.J Psychopharmacol. 2017 Sep;31(9):1250-1262. doi: 10.1177/0269881117724353. Epub 2017 Aug 31. J Psychopharmacol. 2017. PMID: 28857657
-
A new animal model for the prediction of antidepressant activity.Pharmakopsychiatr Neuropsychopharmakol. 1977 Mar;10(2):96-100. doi: 10.1055/s-0028-1094525. Pharmakopsychiatr Neuropsychopharmakol. 1977. PMID: 616925
-
The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice.Neurosci Biobehav Rev. 2005;29(4-5):571-625. doi: 10.1016/j.neubiorev.2005.03.009. Neurosci Biobehav Rev. 2005. PMID: 15890404 Review.
-
The olfactory bulbectomy model in mice and rat: one story or two tails?Eur J Pharmacol. 2015 Apr 15;753:105-13. doi: 10.1016/j.ejphar.2014.10.033. Epub 2014 Nov 7. Eur J Pharmacol. 2015. PMID: 25446558 Review.
Cited by
-
Targeting GLP-1 receptors to reduce nicotine use disorder: Preclinical and clinical evidence.Physiol Behav. 2024 Jul 1;281:114565. doi: 10.1016/j.physbeh.2024.114565. Epub 2024 Apr 23. Physiol Behav. 2024. PMID: 38663460 Free PMC article. Review.
-
Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammation.JHEP Rep. 2023 Dec 21;6(3):100992. doi: 10.1016/j.jhepr.2023.100992. eCollection 2024 Mar. JHEP Rep. 2023. PMID: 38415019 Free PMC article.
-
Ketogenic diet and behavior: insights from experimental studies.Front Nutr. 2024 Feb 8;11:1322509. doi: 10.3389/fnut.2024.1322509. eCollection 2024. Front Nutr. 2024. PMID: 38389795 Free PMC article. Review.
-
Assessment of commonly used tests in experimental depression studies according to behavioral patterns of rodents.Med Rev (2021). 2023 Nov 1;3(6):526-531. doi: 10.1515/mr-2023-0018. eCollection 2023 Dec. Med Rev (2021). 2023. PMID: 38282796 Free PMC article.
-
Effect of a New Substance with Pyridoindole Structure on Adult Neurogenesis, Shape of Neurons, and Behavioral Outcomes in a Chronic Mild Stress Model in Rats.Int J Mol Sci. 2024 Jan 10;25(2):845. doi: 10.3390/ijms25020845. Int J Mol Sci. 2024. PMID: 38255918 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
